- Marquis Who's Who Honors Nour Farahat for Expertise in Medical Communications and Events Management
(April 9, 2025) Nour Farahat celebrates years of success as a leading executive at MedForce and founder of Nour Events - Humabiologics Introduces Research-Grade Human Collagen to Support Scientists Amid Funding Challenges
(April 9, 2025) First-ever human collagen priced below animal alternatives removes final barrier for researchers to adopt clinically relevant biomaterials - Marquis Who's Who Honors Jane Brandman, MS, for Expertise in Health Care
(April 8, 2025) Jane Brandman, MS, is a leader making a mark on the pharmaceutical industry - Marquis Who's Who Honors Harvey W. Kaufman, MD, for Excellence in Health Care
(April 8, 2025) Harvey W. Kaufman, MD, has over 40 years of experience as an expert in pathology - CD BioSciences Unlocks Drug Discovery and Development with Integrated Imaging Analysis Services
(April 8, 2025) CD BioSciences offers integrated imaging analysis services to accelerate preclinical drug discovery and development. - Dr. Steven Victor Celebrated for Contributions to the Health Care Sector
(April 3, 2025) Dr. Steven Victor honored for more than 40 years of professional success in innovations - Diane K. Reist Featured in Marquis Who's Who Millennium Magazine
(April 2, 2025) Diane K. Reist earns prominent placement in Millennium Magazine's Eighteenth Edition - Marquis Who's Who Honors Dr. Paula J. Shadle for Excellence in Consulting Services
(April 2, 2025) Dr. Paula J. Shadle is a renowned consultant and scientist with a career spanning across four decades - Jose M. Silveiras, MD, Celebrated for Accomplishments in Research and Development in the Health Care Sector
(April 1, 2025) Jose M. Silveiras, MD, is the executive director of site relationships and clinical monitoring at Zenas BioPharma Inc. - NewAge™ Industries, Inc., Parent Company of AdvantaPure™ and Carolina Components Group Announce a Collaboration
(March 31, 2025) NewAge™ Industries, Inc., Parent Company of AdvantaPure™ and Carolina Components Group Announce a Collaboration to Co-Develop and Co-Market Sustainable Solutions for Single-Use BioPharma Manufacturing - Marquis Who's Who Honors Mai H. Johnson, PhD, for Expertise in Medical Research
(March 31, 2025) Mai H. Johnson, PhD, is a distinguished expert in cancer research and therapeutic development with 25 years of dedicated service in the medical industry - Try Ace Therapeutics' Cardiac Organoid Models to Speed Up In Vitro Cardiovascular Disease Research
(March 29, 2025) Ace Therapeutics develops tailored cardiac organoids for cardiovascular drug screening and assessment and cardiovascular regenerative medicine. - A Review of Latest Tools and Technologies in Pharmaceutical Research
(March 29, 2025) A Review of Latest Tools and Technologies in Pharmaceutical Research - Creative Biolabs Captures the Spotlight at Scientist Solution Vendor Event, Johns Hopkins
(March 28, 2025) Creative Biolabs attended the Scientist Solution Vendor Event at Johns Hopkins University on March 13 as an industry exhibitor. - Creative Biolabs' Comprehensive Monkeypox Vaccine Discovery Solutions to Combat the Virus
(March 27, 2025) Creative Biolabs is a pioneer in innovation, offering cutting-edge technologies and expertise to facilitate the development of effective monkeypox vaccines. - Fueling TIL Therapy Development: Creative Biolabs Offers Expert, End-to-End Support
(March 26, 2025) As a reliable collaborator in immunotherapy research, Creative Biolabs offers a true one-stop TIL therapy development service from research and development commencement to preclinical research. - Marquis Who's Who Honors Samuel Li, PhD, for Expertise in Life Sciences, Biotechnology and Pharmaceuticals
(March 24, 2025) Samuel Li, PhD, is a distinguished scientist with 35 years of experience in the life sciences, biotechnology and biopharmaceutical industries - Marquis Who's Who Honors Narendrasinh Gohil for Expertise in the Pharmaceutical Industry
(March 24, 2025) Narendrasinh Gohil is a distinguished expert in quality assurance with four decades of experience in the pharmaceutical industry - Skin, Bones, Hearts & Private Parts Hosts Myrtle Beach, South Carolina CME Conference in Primary and Specialty Care Settings
(March 23, 2025) Continuing Medical Education for Nurse Practitioners, Physician Assistants, Registered Nurses & Physicians - Creative Biolabs Accelerates Lipid-Based Drug Delivery Innovation with Enhanced Service Portfolio
(March 21, 2025) With greater commitment to innovation, Creative Biolabs is empowering pharmaceutical companies and researchers to transcend the confines of drug delivery. - SignaBlok to Present Preclinical Data on TREM-1-Targeting Drug for the Treatment of Sepsis, Pulmonary Inflammation and Fibrosis at the Respiratory Innovation Summit and ATS Conference 2025
(March 20, 2025) We will present paradigm-shifting preclinical data on targeting innate inflammation to protect septic mice from death at delayed treatment times as well as to reduce pulmonary inflammation and reverse fibrosis in animal models of lung pathologies. - Marquis Who's Who Honors Mary Smith for Her Roles as a CEO, Independent Director and National Thought Leader
(March 20, 2025) Mary Smith is a corporate director, attorney and expert in the health care and regulatory compliance sectors - SignaBlok to Present Preclinical Data on TREM-1-Targeting Drug for the Treatment of Cancer at the American Association for Cancer Research (AACR) Annual Meeting 2025
(March 19, 2025) We will present preclinical data on targeting innate inflammation to prevent pancreatic cancer recurrence, improve complete response and survival rate in chemotherapy-treated mice, and overcome cancer resistance in those treated with immunotherapy. - Anzor Pharmaceuticals to Present at Chronic Kidney Disease Conference
(March 19, 2025) FGF TECHNOLOGY REPRESENTS MAJOR BREAKTHROUGH IN METABOLIC AND CANCER DISEASES - Ginsenoside Supplement Redsenol-1 Plus Included in National Cancer Institute's Drug Dictionary
(March 13, 2025) A milestone achievement in botanical therapeutics - Marquis Who's Who Honors Amanda Way for Expertise in Health Care
(March 13, 2025) Amanda Way is a pioneering expert in health care technology - ADAP Advocacy Releases New Policy Paper on 340B Drug Pricing Program
(March 12, 2025) Is the 340B Drug Pricing Program the Next 'Too Big to Fail'? - ADAP Advocacy Releases Supplemental Report on 340B Covered Entities
(March 4, 2025) The 340B Drug Pricing Program and Its Potential Impacts on Annual Revenues, Executive Compensation, and Charity Care Provision in Eligible Covered Entities - Xiaokui Zhang, PhD, Recognized for Success in Research and Development in the Biopharmaceuticals Industry
(February 28, 2025) Xiaokui Zhang, PhD, is the chief scientific officer at Aspen Neuroscience Inc. - Andarix Pharmaceuticals CEO to Chair Radiopharmaceutical Conference
(February 27, 2025) Targeted Radiotherapies: A New Approach to Treating Cancer
Friday, 17 June 2011
Pharmaceutical News
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment